Timeline
Last
$112.86
+13.41 (13.48%)
24HR+13.5%
1W+32.0%
1M+12.9%
1Y+310.1%
Valuation
- Market Cap
- $7.1B
- Enterprise Value
- $6.2B
- P/E (TTM)
- —
- Forward P/E
- -179.13x
- Price / Sales
- 16.39x
- EV / EBITDA
- -53.59x
Cash Flow
- Operating Cash Flow
- -$53.1M
- Free Cash Flow
- -$64.8M
- FCF Margin
- -15.0%
- Cash Conversion
- 122.1%
- Cash / Share
- $2.7
Margins & Growth
- Gross Margin
- 52.0%
- Operating Margin
- -30.6%
- EBITDA Margin
- -26.7%
- Net Margin
- -31.7%
- Revenue Growth
- 23.2%
- Earnings Growth
- —
Balance Sheet
- Total Cash
- $166.8M
- Total Debt
- $108.6M
- Net Cash
- $58.2M
- Debt / Equity
- 0.24x
- Current Ratio
- 2.67x
- Quick Ratio
- 1.98x
Returns & Ownership
- Return on Assets
- -13.1%
- Return on Equity
- -29.6%
- Dividend Yield
- —
- Payout Ratio
- 0.0%
- Beta
- 2.16
- Institutional Ownership
- 126.4%
Latest EPS-$0.56-2.1% surprise
Beat rate50%4 prints
Avg surprise-0.5%vs consensus
Next printAug 3, 2026EPS -$0.02
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
-$0.02$123.5M+95.6%+1QDec 2026
-$0.05$125.2M+91.0%0YSep 2026
-$0.63$455.3M+70.2%+1YSep 2027
-$0.63$537.0M+0.0%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
8-KCorporate Changes & Voting Matters2026-08-038-KCorporate Changes & Voting Matters2026-05-048-KCorporate Changes & Voting Matters2026-02-178-KCorporate Changes & Voting Matters2026-02-068-KCorporate Changes & Voting Matters2026-02-028-KCorporate Changes & Voting Matters2026-01-1210-KPeriodic Financial Reports2025-11-178-KCorporate Changes & Voting Matters2025-11-148-KCorporate Changes & Voting Matters2025-08-068-KCorporate Changes & Voting Matters2025-08-048-KCorporate Changes & Voting Matters2025-05-058-KCorporate Changes & Voting Matters2025-02-11
TWST stock research · Twist Bioscience Corporation
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targ…
| Last price | $112.9 |
|---|---|
| Day change | +13.41 (13.48%) |
| Market cap | $7.1B |
| P/E (TTM) | — |
| Sector | Healthcare |
| Industry | Diagnostics & Research |